Key Information
Source
Amyloidosis Support Groups
Year
2022
summary/abstract
Antibodies (Plasma Cells) Therapy for AL Amyloidosis 2022 lists different medications and therapies for treating AL amyloidosis, a blood disorder characterized by abnormal deposits of a protein called immunoglobulin light chain in various organs and tissues of the body. The table is divided into several categories: Alkylating Agents, Proteasome Inhibitors, Steroids, IMiDs, Fibril-Directed Agents, and Light Chain Stabilizers. Some of the therapies listed in the table have FDA approval. The FDA-approved medication for AL Amyloidosis is Dara-CyBorD, a combination of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone.
Abstract Source
https://drive.google.com/file/d/114wgWS8fkjm8S4ZAqugOATp80NOWL1eB/view